Raras
Buscar doenças, sintomas, genes...
Epilepsia generalizada com convulsões febris-plus
ORPHA:36387CID-10 · G40.3CID-11 · 8A61.2YPCDT · SUSDOENÇA RARA

Uma condição de epilepsia que se manifesta em famílias, onde as pessoas da mesma família podem ter crises convulsivas. Essas crises se enquadram em um grupo de condições chamado "epilepsia generalizada com convulsões febris plus" (GEFS+). Elas podem variar desde convulsões simples causadas por febre (CF) até formas mais sérias, como a epilepsia mioclônica-astática (EMA) ou a síndrome de Dravet (SD).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma condição de epilepsia que se manifesta em famílias, onde as pessoas da mesma família podem ter crises convulsivas. Essas crises se enquadram em um grupo de condições chamado "epilepsia generalizada com convulsões febris plus" (GEFS+). Elas podem variar desde convulsões simples causadas por febre (CF) até formas mais sérias, como a epilepsia mioclônica-astática (EMA) ou a síndrome de Dravet (SD).

Publicações científicas
10 artigos
Último publicado: 2025 Feb

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Childhood
🏥
SUS: Cobertura parcialScore: 45%
PCDT disponívelCID-10: G40.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
28 sintomas
🦴
Ossos e articulações
2 sintomas
🧬
Pele e cabelo
1 sintomas
🫃
Digestivo
1 sintomas
😀
Face
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

90%prev.
Crise de início generalizado
Muito frequente (99-80%)
55%prev.
Crise não motora (ausência) generalizada
Frequente (79-30%)
55%prev.
Convulsão febril (na faixa etária de 3 meses a 6 anos)
Frequente (79-30%)
17%prev.
Atrofia/hipoplasia cerebral generalizada
Ocasional (29-5%)
17%prev.
Crise atônica
Ocasional (29-5%)
17%prev.
Comprometimento cognitivo
Ocasional (29-5%)
42sintomas
Muito frequente (1)
Frequente (2)
Ocasional (13)
Muito raro (12)
Sem dados (14)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 42 características clínicas mais associadas, ordenadas por frequência.

Crise de início generalizadoGeneralized-onset seizure
Muito frequente (99-80%)90%
Crise não motora (ausência) generalizadaGeneralized non-motor (absence) seizure
Frequente (79-30%)55%
Convulsão febril (na faixa etária de 3 meses a 6 anos)Febrile seizure (within the age range of 3 months to 6 years)
Frequente (79-30%)55%
Atrofia/hipoplasia cerebral generalizadaGeneralized cerebral atrophy/hypoplasia
Ocasional (29-5%)17%
Crise atônicaAtonic seizure
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico10PubMed
Últimos 10 anos10publicações
Pico20213 papers
Linha do tempo
2025Hoje · 2026🧪 2015Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant.

GABRG2Gamma-aminobutyric acid receptor subunit gamma-2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:16412217, PubMed:23909897, PubMed:2538761, PubMed:25489750, PubMed:27864268, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit in

LOCALIZAÇÃO

Postsynaptic cell membraneCell membraneCell projection, dendriteCytoplasmic vesicle membrane

VIAS BIOLÓGICAS (2)
GABA receptor activationSignaling by ERBB4
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 74

A form of epileptic encephalopathy, a heterogeneous group of severe early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE74 is an autosomal dominant form with onset in the first year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
20.3 TPM
Brain Frontal Cortex BA9
19.4 TPM
Cerebelo
15.3 TPM
Córtex cerebral
10.6 TPM
Brain Nucleus accumbens basal ganglia
7.7 TPM
OUTRAS DOENÇAS (7)
febrile seizures, familial, 8developmental and epileptic encephalopathy, 74obsolete Dravet syndromechildhood absence epilepsy
HGNC:4087UniProt:P18507
SCN1ASodium channel protein type 1 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.1, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 2

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
15.1 TPM
Cérebro - Hemisfério cerebelar
10.7 TPM
Cerebelo
9.3 TPM
Córtex cerebral
8.9 TPM
Hipotálamo
6.3 TPM
OUTRAS DOENÇAS (13)
developmental and epileptic encephalopathy, 6Ageneralized epilepsy with febrile seizures plus, type 2developmental and epileptic encephalopathy 6Bfamilial hemiplegic migraine
HGNC:10585UniProt:P35498
SLC32A1Vesicular inhibitory amino acid transporterDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity). Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)

LOCALIZAÇÃO

Cytoplasmic vesicle membranePresynapse

VIAS BIOLÓGICAS (1)
GABA synthesis, release, reuptake and degradation
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 12

An autosomal dominant neurologic disorder with variable expressivity and incomplete penetrance. Affected individuals have variable types of seizures, most often febrile seizures, sometimes combined with non-febrile focal or generalized seizures. Rarely, afebrile tonic-clonic seizures have been observed.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
51.3 TPM
Brain Caudate basal ganglia
26.5 TPM
Hipotálamo
16.1 TPM
Cerebelo
15.7 TPM
Brain Putamen basal ganglia
15.7 TPM
OUTRAS DOENÇAS (4)
generalized epilepsy with febrile seizures plus, type 12developmental and epileptic encephalopathy 114early-infantile DEEgeneralized epilepsy with febrile seizures plus
HGNC:11018UniProt:Q9H598
PRRT2Proline-rich transmembrane protein 2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

As a component of the outer core of AMPAR complex, may be involved in synaptic transmission in the central nervous system. In hippocampal neurons, in presynaptic terminals, plays an important role in the final steps of neurotransmitter release, possibly by regulating Ca(2+)-sensing. In the cerebellum, may inhibit SNARE complex formation and down-regulate short-term facilitation

LOCALIZAÇÃO

Cell membranePresynaptic cell membraneSynapseCell projection, axonCytoplasmic vesicle, secretory vesicle, synaptic vesicle membranePostsynaptic density membraneCell projection, dendritic spine

MECANISMO DE DOENÇA

Episodic kinesigenic dyskinesia 1

An autosomal dominant form of paroxysmal kinesigenic dyskinesia, a neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
606.4 TPM
Cérebro - Hemisfério cerebelar
563.4 TPM
Ovário
183.2 TPM
Brain Frontal Cortex BA9
167.2 TPM
Córtex cerebral
152.5 TPM
OUTRAS DOENÇAS (9)
episodic kinesigenic dyskinesia 1seizures, benign familial infantile, 2infantile convulsions and choreoathetosisfamilial or sporadic hemiplegic migraine
HGNC:30500UniProt:Q7Z6L0
ADGRV1Adhesion G-protein coupled receptor V1Candidate gene tested inTolerante
FUNÇÃO

G-protein coupled receptor which has an essential role in the development of hearing and vision. Couples to G-alpha(i)-proteins, GNAI1/2/3, G-alpha(q)-proteins, GNAQ, as well as G-alpha(s)-proteins, GNAS, inhibiting adenylate cyclase (AC) activity and cAMP production. Required for the hair bundle ankle formation, which connects growing stereocilia in developing cochlear hair cells of the inner ear. In response to extracellular calcium, activates kinases PKA and PKC to regulate myelination by inh

LOCALIZAÇÃO

Cell membraneCell projection, stereocilium membranePhotoreceptor inner segment

VIAS BIOLÓGICAS (1)
EGR2 and SOX10-mediated initiation of Schwann cell myelination
MECANISMO DE DOENÇA

Usher syndrome 2C

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

OUTRAS DOENÇAS (4)
Usher syndrome type 2Cfebrile seizures, familial, 4Usher syndrome type 2generalized epilepsy with febrile seizures plus
HGNC:17416UniProt:Q8WXG9
CPA6Carboxypeptidase A6Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II (PubMed:18178555). Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine (PubMed:20855895)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

OUTRAS DOENÇAS (4)
familial temporal lobe epilepsy 5febrile seizures, familial, 11familial mesial temporal lobe epilepsygeneralized epilepsy with febrile seizures plus
HGNC:17245UniProt:Q8N4T0
STX1BSyntaxin-1BDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Potentially involved in docking of synaptic vesicles at presynaptic active zones. May mediate Ca(2+)-regulation of exocytosis acrosomal reaction in sperm (By similarity)

LOCALIZAÇÃO

MembraneNucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindle

VIAS BIOLÓGICAS (2)
LGI-ADAM interactionsToxicity of botulinum toxin type C (botC)
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 9

An autosomal dominant neurologic disorder characterized by febrile and/or afebrile seizures manifesting in early childhood. Seizure are variable and include generalized tonic-clonic, atonic, myoclonic, complex partial, and absence types. Most patients have remission of seizures later in childhood with no residual neurologic deficits. Rarely, patients may show mild developmental delay or mild intellectual disabilities.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
309.3 TPM
Cérebro - Hemisfério cerebelar
299.9 TPM
Córtex cerebral
153.6 TPM
Brain Frontal Cortex BA9
151.9 TPM
Brain Anterior cingulate cortex BA24
90.8 TPM
OUTRAS DOENÇAS (2)
generalized epilepsy with febrile seizures plus, type 9generalized epilepsy with febrile seizures plus
HGNC:18539UniProt:P61266
FGF13Fibroblast growth factor 13Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Microtubule-binding protein which directly binds tubulin and is involved in both polymerization and stabilization of microtubules (By similarity). Through its action on microtubules, may participate in the refinement of axons by negatively regulating axonal and leading processes branching (By similarity). Plays a crucial role in neuron polarization and migration in the cerebral cortex and the hippocampus (By similarity). Regulates voltage-gated sodium channel transport and function (PubMed:15282

LOCALIZAÇÃO

NucleusCytoplasmCell projection, filopodiumCell projection, growth coneCell projection, dendriteCell membrane, sarcolemma

VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 90

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE90 is an X-linked form characterized by onset of refractory seizures in the first days or months of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
9.7 TPM
Brain Nucleus accumbens basal ganglia
8.9 TPM
Hipocampo
8.3 TPM
Brain Anterior cingulate cortex BA24
8.2 TPM
Cérebro - Amígdala
5.7 TPM
OUTRAS DOENÇAS (3)
intellectual developmental disorder, X-linked 110developmental and epileptic encephalopathy, 90generalized epilepsy with febrile seizures plus
HGNC:3670UniProt:Q92913
SCN2ASodium channel protein type 2 subunit alphaCandidate gene tested inAltamente restrito
FUNÇÃO

Mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which Na(+) ions may pass in accordance with their electrochemical gradient (PubMed:1325650, PubMed:17021166, PubMed:28256214, PubMed:29844171). Implicated in the regulation of hippocampal replay occurring within sharp wave ripples (SPW-R) important for memory (By simi

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Seizures, benign familial infantile, 3

A form of benign familial infantile epilepsy, a neurologic disorder characterized by afebrile seizures occurring in clusters during the first year of life, without neurologic sequelae. BFIS3 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
70.3 TPM
Cerebelo
65.2 TPM
Brain Frontal Cortex BA9
19.3 TPM
Córtex cerebral
11.5 TPM
Brain Nucleus accumbens basal ganglia
9.1 TPM
OUTRAS DOENÇAS (10)
seizures, benign familial infantile, 3episodic ataxia, type 9developmental and epileptic encephalopathy, 11complex neurodevelopmental disorder
HGNC:10588UniProt:Q99250
SCN9ASodium channel protein type 9 subunit alphaCandidate gene tested inTolerante
FUNÇÃO

Pore-forming subunit of Nav1.7, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneCell projection, neuron projectionCell projection, axon

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Primary erythermalgia

Autosomal dominant disease characterized by recurrent episodes of severe pain associated with redness and warmth in the feet or hands.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
8.9 TPM
Nervo tibial
8.9 TPM
Hipotálamo
7.5 TPM
Cólon sigmoide
6.3 TPM
Baço
5.3 TPM
OUTRAS DOENÇAS (7)
channelopathy-associated congenital insensitivity to pain, autosomal recessiveparoxysmal extreme pain disorderprimary erythermalgiaobsolete sodium channelopathy-related small fiber neuropathy
HGNC:10597UniProt:Q15858
HCN1Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Hyperpolarization-activated ion channel that are permeable to sodium and potassium ions (PubMed:15351778, PubMed:28086084). Displays lower selectivity for K(+) over Na(+) ions (PubMed:28086084). Contributes to the native pacemaker currents in heart (If) and in the generation of the I(h) current which controls neuron excitability (PubMed:29936235, PubMed:30351409). Participates in cerebellar mechanisms of motor learning (By similarity). May mediate responses to sour stimuli (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
HCN channels
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 24

A disease characterized by early-onset seizures, intellectual disability of varying degrees, and behavioral disturbances or autistic features in most individuals.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Frontal Cortex BA9
9.1 TPM
Cérebro - Hemisfério cerebelar
5.7 TPM
Nervo tibial
5.3 TPM
Córtex cerebral
5.2 TPM
Cerebelo
4.9 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
generalized epilepsy with febrile seizures plus, type 10developmental and epileptic encephalopathy, 24undetermined early-onset epileptic encephalopathygeneralized epilepsy with febrile seizures plus
HGNC:4845UniProt:O60741
GABRDGamma-aminobutyric acid receptor subunit deltaCandidate gene tested inTolerante
FUNÇÃO

Delta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:35355020). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:35355020). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the

LOCALIZAÇÃO

Cell membrane

MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 5

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
538.4 TPM
Cerebelo
517.0 TPM
Brain Frontal Cortex BA9
104.9 TPM
Córtex cerebral
95.3 TPM
Brain Nucleus accumbens basal ganglia
54.4 TPM
OUTRAS DOENÇAS (4)
chromosome 1p36 deletion syndromegeneralized epilepsy with febrile seizures plusjuvenile myoclonic epilepsyepilepsy, idiopathic generalized, susceptibility to, 10
HGNC:4084UniProt:O14764
SCN1BSodium channel regulatory subunit beta-1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke

LOCALIZAÇÃO

Cell membranePerikaryonCell projectionCell projection, axonSecreted

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 1

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
166.3 TPM
Cérebro - Hemisfério cerebelar
165.4 TPM
Músculo esquelético
108.1 TPM
Brain Frontal Cortex BA9
81.3 TPM
Córtex cerebral
67.1 TPM
OUTRAS DOENÇAS (11)
generalized epilepsy with febrile seizures plus, type 1developmental and epileptic encephalopathy, 52Brugada syndrome 5atrial fibrillation, familial, 13
HGNC:10586UniProt:Q07699

Variantes genéticas (ClinVar)

3,245 variantes patogênicas registradas no ClinVar.

🧬 GABRG2: NM_198904.4(GABRG2):c.1128+3A>T ()
🧬 GABRG2: NM_198904.4(GABRG2):c.1272_1273delinsG (p.Ser424fs) ()
🧬 GABRG2: NM_198904.4(GABRG2):c.940A>G (p.Thr314Ala) ()
🧬 GABRG2: NM_198904.4(GABRG2):c.361T>C (p.Trp121Arg) ()
🧬 GABRG2: NM_198904.4(GABRG2):c.317C>A (p.Ala106Asp) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Epilepsia generalizada com convulsões febris-plus

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

0 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
10 papers (10 anos)
#1

Two Molecular Diagnoses in an Individual with Hailey-Hailey Disease and Genetic Epilepsy with Febrile Seizure Plus.

Indian journal of pediatrics2025 Feb
#2

Deciphering the Complexities of Sodium Voltage-Gated Channel Alpha Subunit 1 (SCN1A) Mutation: A Case of Intractable Epilepsy in a Five-and-a-Half-Month-Old Male.

Cureus2024 Jul

If the sodium voltage-gated channel alpha subunit 1 (SCN1A) gene, which encodes Nav1.1 protein, undergoes pathological mutation, it results in a wide range of epileptic syndrome, including febrile seizure, genetic epilepsy with febrile seizure plus (GEFS+), and developmental and epileptic encephalopathy (DEE), including Dravet syndrome. We present the case of a five-and-a-half-month-old boy with SCN1A gene-related epileptic seizures, starting as focal seizures and progressing to generalized tonic-clonic seizures. Despite treating the seizures with multiple antiepileptic drugs, including phenytoin, sodium valproate, levetiracetam, perampanel, and clobazam, it was very difficult to control the seizures, and genetic testing was suggested. The SCN1A mutation leads to either loss of function, including GEFS+ and Dravet syndrome, or gain of function, including familial hemiplegic migraine type 3. The case emphasizes the importance of genetic testing in refractory epilepsy management to provide medical strategies for the diagnosis. It focuses on the difficulties faced in diagnostic and treatment strategies for the management of SCN1A-related epilepsy. It emphasizes the importance of monitoring and personalized treatment strategies to reduce the incidence of refractory epilepsy.

#3

Clinical and electroencephalographic findings prior to the onset of juvenile myoclonic epilepsy: A case series.

Epileptic disorders : international epilepsy journal with videotape2023 Feb

The purpose of this study was to investigate the timing of generalized electroencephalographic abnormalities in patients with juvenile myoclonic epilepsy who were followed up long term before the onset of juvenile myoclonic epilepsy. We enrolled juvenile myoclonic epilepsy patients whose course of epilepsy had been observed for >5 years before the onset of juvenile myoclonic epilepsy, those who had undergone electroencephalogram recording more than twice before the onset of juvenile myoclonic epilepsy, and those who had terminated antiseizure medications for at least 2 years before the onset of juvenile myoclonic epilepsy. Patients who had transitioned from childhood absence epilepsy to juvenile myoclonic epilepsy were excluded. We retrospectively reviewed the medical records and neurophysiological data of the patients. Four patients met the inclusion criteria. One patient was diagnosed with febrile seizures during childhood, and the remaining three had transitioned to juvenile myoclonic epilepsy from other epileptic disorders, such as self-limited epilepsy with autonomic seizures, genetic epilepsy with febrile seizure plus, or nonspecific genetic generalized epilepsy. All patients exhibited generalized spike-wave discharges or photoparoxysmal responses for >2 years before the onset of juvenile myoclonic epilepsy. The four patients had transitioned to juvenile myoclonic epilepsy from other epileptological preconditions. Patients with juvenile myoclonic epilepsy may show generalized electroencephalographic abnormality many years prior to the onset of symptoms. Generalized spike-waves on the electroencephalogram during the course of any type of epilepsy or febrile seizure may be a risk factor for developing juvenile myoclonic epilepsy.

#4

Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.

CNS &amp; neurological disorders drug targets2022

Febrile Seizures (FS) are the most common seizures in children younger than 5 years. In the last decade, various coding and noncoding sequence variations of voltage-gated sodium channels SCN2A have been identified in patients with seizures, implying their genetic base. We aimed to evaluate the association between SCN2A c. G/A genetic polymorphism among Egyptian children with febrile seizure plus. The present cross-sectional study was carried out on 100 epileptic infants and children, attendants of the Neurology Unit, pediatric department, Menoufia University Hospitals (Group Ι). The patients were sub-classified into two groups, according to response to anti-epileptic treatment; Group Ι a (drug responder) and Group Ι b (drug-resistant). Evenly divided number of apparently healthy, age and gender-matched children were selected as controls (Group II). A complete history, throughout the systemic examination and radiological & metabolic assessment, whenever needed was provided, all participants were genotyped for SCN2A rs17183814 polymorphism by Restriction Fragment Length Polymorphism (PCR-RFLP). Both of A allele and AA, GA genotypes of SCN2A c. 56 G/A were detected more in patients with febrile seizure plus comparison to the control group with a statistically significant difference at frequencies of 17% and 11% and 12% respectively; OR (CI95%): 10.04 (3.49-28.87) and p <0.001. On classifying epileptic patients into 2 subgroups, carriers of SCN2A rs17183814 AA genotype tended to respond poorly to Anti-epileptic Drugs (AEDs). Moreover, multivariate analysis revealed that rs17183814 A allele and positive family history of epilepsy were considered the highest predicted risk factors for the development of epilepsy; p<0.05. SCN2A rs17183814 (A) allele was specifically associated with developing febrile seizure plus and could modulate the patient's response to anti-epileptic medications.

#5

The Broad Clinical Spectrum of Epilepsies Associated With Protocadherin 19 Gene Mutation.

Frontiers in neurology2021

Protocadherin 19 (PCDH19) gene is one of the most common genes involved in epilepsy syndromes. According to literature data PCDH19 is among the 6 genes most involved in genetic epilepsies. PCDH19 is located on chromosome Xq22.1 and is involved in neuronal connections and signal transduction. The most frequent clinical expression of PCDH19 mutation is epilepsy and mental retardation limited to female (EFMR) characterized by epileptic and non-epileptic symptoms affecting mainly females. However, the phenotypic spectrum of these mutations is considerably variable from genetic epilepsy with febrile seizure plus to epileptic encephalopathies. The peculiar exclusive involvement of females seems to be caused by a cellular interference in heterozygosity, however, affected mosaic-males have been reported. Seizure types range from focal seizure to generalized tonic-clonic, tonic, atonic, absences, and myoclonic jerks. Treatment of PCDH19-related epilepsy is limited by drug resistance and by the absence of specific treatment indications. However, seizures become less severe with adolescence and some patients may even become seizure-free. Non-epileptic symptoms represent the main disabilities of adult patients with PCDH19 mutation. This review aims to analyze the highly variable phenotypic expression of PCDH19 gene mutation associated with epilepsy.

Publicações recentes

Ver todas no PubMed

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Epilepsia generalizada com convulsões febris-plus.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Epilepsia generalizada com convulsões febris-plus

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Two Molecular Diagnoses in an Individual with Hailey-Hailey Disease and Genetic Epilepsy with Febrile Seizure Plus.
    Indian journal of pediatrics· 2025· PMID 39673595mais citado
  2. Deciphering the Complexities of Sodium Voltage-Gated Channel Alpha Subunit 1 (SCN1A) Mutation: A Case of Intractable Epilepsy in a Five-and-a-Half-Month-Old Male.
    Cureus· 2024· PMID 39119390mais citado
  3. Clinical and electroencephalographic findings prior to the onset of juvenile myoclonic epilepsy: A case series.
    Epileptic disorders : international epilepsy journal with videotape· 2023· PMID 36946369mais citado
  4. Role of SCN2A c.56G/A Gene Polymorphism in Egyptian Children with Genetic Epilepsy with Febrile Seizure Plus.
    CNS &amp; neurological disorders drug targets· 2022· PMID 34607551mais citado
  5. The Broad Clinical Spectrum of Epilepsies Associated With Protocadherin 19 Gene Mutation.
    Frontiers in neurology· 2021· PMID 35111125mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:36387(Orphanet)
  2. MONDO:0018214(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:18641(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q16909671(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Epilepsia generalizada com convulsões febris-plus
Compêndio · Raras BR

Epilepsia generalizada com convulsões febris-plus

ORPHA:36387 · MONDO:0018214
🇧🇷 Brasil SUS
Geral
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
G40.3 · Epilepsia e síndromes epilépticas generalizadas idiopáticas
CID-11
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1858672
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades